视觉障碍-话题@MedSci

#视觉障碍#

9篇内容 | 708人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1661287, encodeId=bbc2166128e3d, content=<a href='/topic/show?id=39c79088173' target=_blank style='color:#2F92EE;'>#视觉障碍#</a>, objectTitle=JPD：帕金森患者，视觉障碍，如何影响其生活质量, objectType=article, longId=727276, objectId=7a0ee27276af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a0ee27276af, replyNumber=0, likeNumber=43, createdTime=2022-08-18, rootId=0, userName=12498484m54(暂无昵称), userId=9a4c25257079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a0ee27276af, moduleTitle=JPD：帕金森患者，视觉障碍，如何影响其生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a0ee27276af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661286, encodeId=3c7b166128632, content=<a href='/topic/show?id=39c79088173' target=_blank style='color:#2F92EE;'>#视觉障碍#</a>, objectTitle=JAMA Netw Open：老年人听力和视觉障碍竟会增加痴呆症风险？, objectType=article, longId=726770, objectId=e9e1e267700f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9e1e267700f, replyNumber=0, likeNumber=51, createdTime=2022-11-02, rootId=0, userName=12498484m54(暂无昵称), userId=9a4c25257079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9e1e267700f, moduleTitle=JAMA Netw Open：老年人听力和视觉障碍竟会增加痴呆症风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9e1e267700f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661285, encodeId=aca51661285bf, content=<a href='/topic/show?id=39c79088173' target=_blank style='color:#2F92EE;'>#视觉障碍#</a>, objectTitle=Mov Disord：帕金森病常见视觉障碍，提示预后不良, objectType=article, longId=197634, objectId=4d9819e63481, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d9819e63481, replyNumber=0, likeNumber=38, createdTime=2020-07-21, rootId=0, userName=12498484m54(暂无昵称), userId=9a4c25257079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d9819e63481, moduleTitle=Mov Disord：帕金森病常见视觉障碍，提示预后不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d9819e63481)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661283, encodeId=829b166128329, content=<a href='/topic/show?id=39c79088173' target=_blank style='color:#2F92EE;'>#视觉障碍#</a>, objectTitle=NEJM：SOLIRIS（eculizumab）治疗神经脊髓炎视觉障碍的III期阳性数据, objectType=article, longId=165432, objectId=e87616543228, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e87616543228, replyNumber=0, likeNumber=24, createdTime=2020-03-07, rootId=0, userName=12498484m54(暂无昵称), userId=9a4c25257079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e87616543228, moduleTitle=NEJM：SOLIRIS（eculizumab）治疗神经脊髓炎视觉障碍的III期阳性数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e87616543228)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661284, encodeId=b5fe1661284ce, content=<a href='/topic/show?id=39c79088173' target=_blank style='color:#2F92EE;'>#视觉障碍#</a>, objectTitle=Satralizumab获得日本孤儿药物认定，用以治疗视网膜神经脊髓炎和神经脊髓炎视觉障碍, objectType=article, longId=179454, objectId=c7ad1e945427, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7ad1e945427, replyNumber=0, likeNumber=37, createdTime=2020-01-01, rootId=0, userName=12498484m54(暂无昵称), userId=9a4c25257079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7ad1e945427, moduleTitle=Satralizumab获得日本孤儿药物认定，用以治疗视网膜神经脊髓炎和神经脊髓炎视觉障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7ad1e945427)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661282, encodeId=3bdb166128250, content=<a href='/topic/show?id=39c79088173' target=_blank style='color:#2F92EE;'>#视觉障碍#</a>, objectTitle=Curr Treat Options Neurol：帕金森综合症视觉障碍的治疗, objectType=article, longId=142187, objectId=258014218e70, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=258014218e70, replyNumber=0, likeNumber=45, createdTime=2018-09-30, rootId=0, userName=12498484m54(暂无昵称), userId=9a4c25257079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=258014218e70, moduleTitle=Curr Treat Options Neurol：帕金森综合症视觉障碍的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=258014218e70)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661281, encodeId=52dc1661281b6, content=<a href='/topic/show?id=39c79088173' target=_blank style='color:#2F92EE;'>#视觉障碍#</a>, objectTitle=J Neuroophthalmol：视觉障碍及相关疾病综述！, objectType=article, longId=115521, objectId=ad80115521d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad80115521d9, replyNumber=0, likeNumber=33, createdTime=2018-06-01, rootId=0, userName=12498484m54(暂无昵称), userId=9a4c25257079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad80115521d9, moduleTitle=J Neuroophthalmol：视觉障碍及相关疾病综述！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad80115521d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661279, encodeId=43c916612e916, content=<a href='/topic/show?id=39c79088173' target=_blank style='color:#2F92EE;'>#视觉障碍#</a>, objectTitle=ARVO 2016：无眼部病变但是高度近视的患者也会出现轻度视觉障碍, objectType=article, longId=67774, objectId=28376e774e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28376e774e0, replyNumber=0, likeNumber=42, createdTime=2017-04-19, rootId=0, userName=12498484m54(暂无昵称), userId=9a4c25257079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28376e774e0, moduleTitle=ARVO 2016：无眼部病变但是高度近视的患者也会出现轻度视觉障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28376e774e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661280, encodeId=43d9166128040, content=<a href='/topic/show?id=39c79088173' target=_blank style='color:#2F92EE;'>#视觉障碍#</a>, objectTitle=Neurology：DTI可用于早期诊断卒中后视觉障碍, objectType=article, longId=71879, objectId=ca00e1879e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca00e1879e0, replyNumber=0, likeNumber=33, createdTime=2017-01-28, rootId=0, userName=12498484m54(暂无昵称), userId=9a4c25257079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca00e1879e0, moduleTitle=Neurology：DTI可用于早期诊断卒中后视觉障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca00e1879e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

视觉障碍

2020-05-29

12498484m54(暂无昵称) (审核中...)

前往app查看评论内容

#视觉障碍#

JPD：帕金森患者，视觉障碍，如何影响其生活质量

2022-08-18

12498484m54(暂无昵称) (审核中...)

前往app查看评论内容

#视觉障碍#

JAMA Netw Open：老年人听力和视觉障碍竟会增加痴呆症风险？

2022-11-02

12498484m54(暂无昵称) (审核中...)

前往app查看评论内容

#视觉障碍#

Mov Disord：帕金森病常见视觉障碍，提示预后不良

2020-07-21

12498484m54(暂无昵称) (审核中...)

前往app查看评论内容

#视觉障碍#

NEJM：SOLIRIS（eculizumab）治疗神经脊髓炎视觉障碍的III期阳性数据

2020-03-07

12498484m54(暂无昵称) (审核中...)

前往app查看评论内容

#视觉障碍#

Satralizumab获得日本孤儿药物认定，用以治疗视网膜神经脊髓炎和神经脊髓炎视觉障碍

2020-01-01

12498484m54(暂无昵称) (审核中...)

前往app查看评论内容

#视觉障碍#

Curr Treat Options Neurol：帕金森综合症视觉障碍的治疗

2018-09-30

12498484m54(暂无昵称) (审核中...)

前往app查看评论内容

#视觉障碍#

J Neuroophthalmol：视觉障碍及相关疾病综述！

2018-06-01

12498484m54(暂无昵称) (审核中...)

前往app查看评论内容

#视觉障碍#

ARVO 2016：无眼部病变但是高度近视的患者也会出现轻度视觉障碍

2017-04-19

12498484m54(暂无昵称) (审核中...)

前往app查看评论内容

#视觉障碍#

Neurology：DTI可用于早期诊断卒中后视觉障碍

2017-01-28

科室
- - 订阅+
  - 更多科室
工具
服务